Synthesis and Evaluation of a Bifunctional Chelator for Thorium-227 Targeted Radiotherapy
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.4c02423 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Joshua J Woods und 7 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States. Hauptthemen laut MEDLINE: Chelating Agents, Thorium, Radioisotopes, Zirconium. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: NIH HHS, Basic Energy Sciences.
Abstract (Originalsprache)
Thorium-227 (227Th) is an α-emitting radionuclide currently under investigation for targeted alpha therapy. Available chelators used for this isotope suffer from challenging multistep syntheses. Here, we present the synthesis and preclinical evaluation of a novel bifunctional chelator, p-SCN-Bn-DOTHOPO, which contains an isothiocyanate group that is suitable for conjugation to biological molecules. This bifunctional chelator was prepared with a 26% overall yield in four steps and conjugated to the human epidermal growth factor receptor 2 targeting antibody, trastuzumab. The resulting immunoconjugate was labeled with [227Th]ThIV (pH 5.5, room temperature, 60 min) with ≥95% radiochemical yield and purity. The conjugate was also labeled with zirconium-89 (89Zr), which can be used for positron emission tomography imaging. The radiometal complexes were subsequently investigated for their biological stability. The results described here provide insight into ligand design strategies and optimization of chelators for the development of the next generation of 89Zr and 227Th radiopharmaceuticals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Chemical Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States.
- Department of Nuclear Engineering, University of California Berkeley, Berkeley, California 94720, United States.
- Department of Chemistry, University of California Berkeley, Berkeley, California 94720, United States.
ORCID-Profile: Joshua J Woods, Jennifer V Alvarenga Vasquez, Rebecca J Abergel
Förderung
- NIH HHS
- Basic Energy Sciences
Zitieren
APA
Woods, J. J., Rigby, A., Wacker, J. N., Arino, T., Alvarenga Vasquez, J. V., Cosby, A., Martin, K. E., & Abergel, R. J. (2025). Synthesis and Evaluation of a Bifunctional Chelator for Thorium-227 Targeted Radiotherapy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c02423
Vancouver
Woods JJ, Rigby A, Wacker JN, Arino T, Alvarenga Vasquez JV, Cosby A, et al. Synthesis and Evaluation of a Bifunctional Chelator for Thorium-227 Targeted Radiotherapy. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c02423
BibTeX
@article{Woods2025,
author = {Woods, Joshua J and Rigby, Alex and Wacker, Jennifer N and Arino, Trevor and Alvarenga Vasquez, Jennifer V and Cosby, Alexia and Martin, Kirsten E and Abergel, Rebecca J},
title = {Synthesis and Evaluation of a Bifunctional Chelator for Thorium-227 Targeted Radiotherapy},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.4c02423}
}
EUVIMED